#abvx
LightNews LightNews
abvx.xyz
First public release v0.1.2-test: lab.abvx
ABVX Lab — a small static hub of ABVX developer tools (GitHub Pages).
https://github.com/markoblogo/lab.abvx?preview=v2
#abvx #aitools
GitHub - markoblogo/lab.abvx: ABVX Lab — a small static hub of ABVX developer tools (GitHub Pages).
ABVX Lab — a small static hub of ABVX developer tools (GitHub Pages). - markoblogo/lab.abvx
github.com
March 19, 2026 at 11:25 PM
tradesviz.bsky.social
Sept 28, 2026: options flow shows bullish $NUAI and $ABVX. $NUAI: six straight sessions, $318K gross, $103K net, 4 contracts, 4 expiries. $ABVX: eight straight, $3.0M gross, $1.2M net, 20 contracts, 11 expiries.
Image description
September 28, 2026 at 12:51 PM
intickers.com
#$ABVX Abivax's Phase 3-validated obefazimod and long cash runway create a credible UC launch path, but its pre-revenue valuation, binary FDA risk, and heavy dilution leave little margin for execution error.
intickers.com/reports/abvx/
ABIVAX Société Anonyme (ABVX) Stock Analysis | InTickers
Abivax's Phase 3-validated obefazimod and long cash runway create a credible UC launch path, but its pre-revenue…
intickers.com
September 27, 2026 at 10:30 PM
insidereu.bsky.social
$ABVX — BlackRock, Inc. crossed 5.1% of ABIVAX.

https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1638

#insiderbuying #europeanstocks #investing
September 28, 2026 at 8:30 PM
sarahgaines.bsky.social
youtube.com/watch?v=abvx...
IHIP News: Elon ATTACKED as ILLEGAL IMMIGRANT as MAGA Calls For DEPORTATION!!
YouTube video by I've Had It
youtube.com
June 6, 2025 at 9:22 PM
abvx.xyz
I published ABVX Agent Skills v0.1.0.

Small, reviewable skills for Codex-style project work: debugging, frontend builds, audits, research, and handoffs.

Not prompt dumps. Reusable operating discipline for AI agents.

github.com/markoblogo/a...

#AI #Agents #Codex #OpenSource
June 3, 2026 at 8:43 AM
bambiopicks.bsky.social
Sold #$LSTA (Lisata)

CEO said in an email that Kuva labs did NOT submit an offer.

#$ABVX #$NKTR #Biotech #$XBI
September 3, 2026 at 1:10 PM
embers.news
Goldman Sachs Initiates Abivax Coverage With Buy Rating and $155 Target

Goldman Sachs has initiated research coverage on clinical-stage biotechnology firm Abivax (NASDAQ: ABVX) wi…

Read more: https://embers.news/article/goldman-sachs-initiates-abivax-coverage-with-buy-rating-and-155-target-73639
Goldman Sachs Initiates Abivax Coverage With Buy Rating and $155 Target
Goldman Sachs has initiated research coverage on clinical-stage biotechnology firm Abivax (NASDAQ: ABVX) with a buy rating and a $155 price target. This initiation reflects analyst expectations for the commercial potential of the company's lead drug candidate, obefazimod, which is currently in devel
embers.news
September 25, 2026 at 2:50 PM
dia1fun.bsky.social
crazy thing is abvx can prob run another 50%+

just in a difficult spot now where the acquisitoin size is now almost too big. similar to insm mdgl etc

dont love how retail crowded it is today though
June 29, 2026 at 11:46 PM
stockquakes.com
#Stocks
Stock Premarket - Jun 03, 2026

See StockQuakes.substack.com

UP
↑ XOS Xos, Inc 217.9%
↑ WCT Wellchange Holdings Co LTD 98.9%
↑ SDOT Sadot Group Inc 66.2%
↑ YMAT J-Star Holding Co, LTD 52.0%
↑ LASE Laser Photonics Corp 40.9%
↑ MSAI Multisensor Ai Holdings 27.3%
↑ ABVX Abivax S.A. 13.9%
StockQuakes | Substack
Using AI to find stock market opportunities. Click to read StockQuakes, by StockQuakes Team, a Substack publication with hundreds of subscribers.
StockQuakes.substack.com
June 3, 2026 at 12:32 PM
robinflow.io
🎯 #$ABVX EARNINGS REACTION

3 analysts updated ABVX (Abivax) after earnings. Not one changed their rating.

Two firms cut: Truist Securities to $151 from $155 at Buy, and Wedbush to $118 from $140 at Neutral.

One kept its target unchanged.
September 22, 2026 at 3:55 PM
abvx.xyz
Released v0.3.0: ABVXsite
Public map of ABVX market infrastructure, AI-native tools, publishing, research, and writing.
https://github.com/markoblogo/ABVXsite?preview=v2
#agrocommodities #aiagents
GitHub - markoblogo/ABVXsite: Public map of ABVX market infrastructure, AI-native tools, publishing, research, and writing.
Public map of ABVX market infrastructure, AI-native tools, publishing, research, and writing. - markoblogo/ABVXsite
github.com
September 14, 2026 at 12:24 PM
v1s1on-3ndl3ss.bsky.social
Despite US Markets Being Closed For Independence Day #AI & #Semiconductor Stocks Rallied Across #Europe & #Asia Today:

#$ASML +6.0%
#$IREN +5.25%
#$TSM +2.6%
#$ABVX +11.2%
#$NVTS +3.2%
#$NBIS +4.7%
#$SNDK +6.6%
#$AAOI +5.6%
#$MU +5.0%
v1s1on-3ndl3ss.bsky.social v1s1on_3ndl3ss_ @v1s1on-3ndl3ss.bsky.social · Jul 3
#US Markets On Close Thursday,July 2,2026

#SP500: -0.01%
#Nasdaq: -1.61%
#Dow: +1.14%
#Russell: -0.55%
#VIX 15.89
#Bitcoin : +2.84%
#2Y: -4.1bp
#10Y: -0.2bp
#30Y: +0.9bp
#WTI #Crude #Oil -0.33%
#Natgas +0.06%
#Gold: +2.03%
#Silver: +2.69%

#Brickell #RealEstate #Office Market 🧐
July 3, 2026 at 8:17 PM
goodetrades.com
#$ABVX Sheep wins again

www.bamsec.com/filing/11931...
LOGO Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database • Obefazimod delivered meaningful clinical benefit in a highly refractory ulcerative colitis (“UC”) population, with 37.2% of induction non-responders achieving clinical remission and 34.5% achieving endoscopic remission at Week 44 following continued 50 mg treatment • Dose escalation to obefazimod 50 mg recaptured clinical remission in 45.5% of patients who relapsed during ABTECT Maintenance Part 1, supporting a practical dose-escalation strategy for regaining and sustaining disease control over time • Across the integrated Phase 2 and Phase 3 UC program (1,704 patient-years of exposure), exposure-adjusted incidence rates (“EAIRs”) for malignancies excluding non-melanoma skin cancer (“NMSC”) were 0.35 and 0.64 events per 100 patient-years (“PYs”), and for NMSC were 0.59 and 0.64 events per 100 PYs in the all-active combined (50 mg + 25 mg) and 50 mg cohorts, respectively, all consistent with expected UC background rates • In ABTECT Maintenance Part 2, EAIRs for malignancies excluding NMSC were 0.48 and 0.69 events per 100 PYs, and for NMSC were 0.95 and 0.69 events per 100 PYs, in the all-active combined and 50 mg cohorts, respectively, all consistent with expected UC background rates • Abivax to host a conference call and webcast today at 4:30 p.m. EDT (10:30 p.m. CEST) to discuss the results PARIS, France – June 29, 2026 – 10:05 pm CEST –
June 29, 2026 at 11:33 PM
stockmarketloop.bsky.social
$ABVX Receives an Analyst Upgrade From Wedbush
Abivax S.A. received a fresh analyst action dated 2026-09-22.
stockmarketloop.com
September 22, 2026 at 1:19 PM
abvx.xyz
First public release v0.1.0: ABVX-OS
Local-first control plane for a personal AI operating system: intake, role routing, portfolio state,.
https://github.com/markoblogo/ABVX-OS?preview=v2
#agenticai #aiagents
GitHub - markoblogo/ABVX-OS: Local-first control plane for a personal AI operating system: intake, role routing, portfolio state, evidence, and human approval gates.
Local-first control plane for a personal AI operating system: intake, role routing, portfolio state, evidence, and human approval gates. - markoblogo/ABVX-OS
github.com
September 13, 2026 at 10:49 PM
abvx.xyz
Released v0.2.0: lab.abvx
Public catalog and control plane for the ABVX AI coding tools stack: repo context, orchestration, sk.
https://github.com/markoblogo/lab.abvx?preview=v2
#abvx #agentsmd
GitHub - markoblogo/lab.abvx: Public catalog and control plane for the ABVX AI coding tools stack: repo context, orchestration, skills, discovery, and proof surfaces.
Public catalog and control plane for the ABVX AI coding tools stack: repo context, orchestration, skills, discovery, and proof surfaces. - markoblogo/lab.abvx
github.com
September 13, 2026 at 8:40 PM
smcapstrategist.bsky.social
Small-cap stocks in new downtrend according to average directional index, Wed Jun 3rd - #$ABVX #$VINP #$UPB #$NXTC #$MGPI #$LWAY #$KMTX #$GERN #$ENTA #$CRAI #$CCBG #$BGL #$ALXO #$UVE #$THW #$SSTK #$GBX #$DLNG #$BRSP #$ARDT - More: crystalequityresearch.com/leading-indi... - #smallcap
Leading Indicators, Wednesday June 3, 2026 – Crystal Equity Research
crystalequityresearch.com
June 3, 2026 at 10:54 PM
paulcerro.bsky.social
Honestly, I didn't think I'd see #$ABVX below $100 again after the June 30th data.

Crazy times we're living in.
September 22, 2026 at 1:44 PM
wealthengine.bsky.social
[The Options Desk] New from Wealth Engine Pro:

"The Options Desk: Why I Passed on ABVX"

A $7.40 weekly premium on a $122 strike. 316% annualized return. And I walked away. Here is how the Put Option Scanner surfaced the trade and why the data said no.

wealthenginepro.com
The Options Desk: Why I Passed on ABVX
A $7.40 weekly premium on a $122 strike. 316% annualized return. And I walked away. Here is how the Put Option Scanner surfaced the trade and why the data said no.
www.wealthenginepro.com
May 22, 2026 at 10:00 PM
stocknear.bsky.social
$ABVX Earnings Release 📝
· Revenue of 3.0M exceeds estimates by 1.1M, with -61.71% YoY decline.
· EPS of -5.2547 misses estimates by -1.35, with 257.46% YoY growth.

Follow up here stocknear.com/stocks/ABVX
September 21, 2026 at 8:39 PM
lourdespujols.bsky.social
www.youtube.com/watch?v=abvx...
Imaginer l'Amour
YouTube video by Lulu Pujols
www.youtube.com
November 24, 2024 at 4:55 PM
fundspec.bsky.social
Abivax $ABVX reported H1 2026 EPS of -$2.43, missing the -$1.08 estimate by 125.0%. Revenue of $3.0M beat the $1.9M estimate by 59.1%.

https://fundspec.ai/s/ABVX/earnings
Momentum scores on thousands of tickers, refreshed every night.
September 21, 2026 at 8:40 PM
stockmarketloop.bsky.social
$ABVX Reports Earnings With a -66.6% EPS Surprise
Fresh reported figures are available in the earnings calendar.
stockmarketloop.com
September 21, 2026 at 11:54 PM